|
Quigley wants cold sufferers to put away their tissues and tonics and chew bubble gum instead. The firm contends its Cold-Eeze remedy (available in lozenge, tablet, and bubble gum form) lessens the length and severity of the common cold. It also has a naturally-derived prescription pharmaceutical subsidiary targeting diabetic neuropathy, radiation dermatitis, and other conditions. The company's Quigley Manufacturing makes Cold-Eeze lozenges, as well as hard and organic candy, and provides contract manufacturing for other firms. Founder and CEO Guy Quigley, who acquired the rights to Cold-Eeze in 1992, owns about a quarter of Quigley Corporation.
|
| | | Contact Information | |
Address: |
The Kells Bldg., 621 Shady Retreat Rd.
Doylestown, PA 18901-2071
| | Phone: | 267-880-1100 | | Fax: | 267-880-1153 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 20.50 M | | Revenue Growth (1 yr): | (-48.10%) | | Employees (2008): | 86 | | Employee Growth (1 yr): | (-31.20%) |
|
|
Key People
| | • |
Chairman and CEO:
Ted Karkus
| | • |
COO:
Robert V. Cuddihy Jr.
| | • |
VP, CFO, and Director:
Gerard M. Gleeson
|
|
|
